BBA
WST icon

Baader Bank Aktiengesellschaft’s West Pharmaceutical WST Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,769
Closed -$380K – 617
2025
Q2 		$380K Buy
+1,769
New +$378K 0.03% 322
2025
Q1 		– Sell
-757
Closed -$247K – 498
2024
Q4 		$247K Buy
757
+28
+4% +$8.81K 0.02% 300
2024
Q3 		$219K Buy
+729
New +$223K 0.01% 364

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Baader Bank Aktiengesellschaft's WST Position: Q3 2025 in Review

Baader Bank Aktiengesellschaft sold out of West Pharmaceutical (WST) in Q3 2025, closing a stake of 1,769 shares — an estimated $380K sold.

Baader Bank Aktiengesellschaft first reported a position in WST in Q3 2024 and held it in 3 quarters. The position peaked at $380K in Q2 2025. 756 funds tracked by Wall St. Rank hold WST as of Q3 2025.

  • Baader Bank Aktiengesellschaft reported no remaining West Pharmaceutical position as of Q3 2025 after selling out during the quarter.
  • Baader Bank Aktiengesellschaft sold 1,769 West Pharmaceutical shares in Q3 2025, an estimated $380K.
  • Baader Bank Aktiengesellschaft first reported a position in West Pharmaceutical in Q3 2024 and held it in 3 quarters.
  • Baader Bank Aktiengesellschaft's West Pharmaceutical position peaked at $380K in Q2 2025.
  • 756 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2025.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q3 2025, filed 6 Nov 2025.